(Albany, US) DelveInsight has launched a new report on Epithelial Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030.
DelveInsight's " Epithelial Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Epithelial Ovarian Cancer, historical and forecasted epidemiology as well as the Epithelial Ovarian Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of Epithelial Ovarian Cancer Facts:
- The rate of new cases of ovarian cancer was 11.2 per 100,000 women per year. The death rate was 6.7 per 100,000 women per year.
- Epithelial ovarian carcinomas (EOC) account for ~90% of all ovarian malignancies.
- In 2020 more than 300 000 new cases of EOC are expected worldwide, with more than 190 000 deaths.
- Ovarian cancer is a disease that affects women. This cancer mainly develops in older women.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-market
View Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market
Scope of Epithelial Ovarian Cancer Report:
- The report covers the descriptive overview of Epithelial Ovarian Cancer, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Epithelial Ovarian Cancer epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Epithelial Ovarian Cancer are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Epithelial Ovarian Cancer market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Epithelial Ovarian Cancer market
Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-market
View Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market
Ovarian cancer is a group of diseases that originates in the ovaries, or in the related areas of the fallopian tubes and the peritoneum. It is one of the most common gynecologic cancers, and one of the leading causes of cancer-associated female mortality in the world. In this form of cancer, certain cells in the ovary become abnormal and multiply uncontrollably to form a tumor. In about 90 percent of cases, ovarian cancer occurs after age 40, and most cases occur after age 60.
The ovaries are mainly made up of 3 kinds of cells. Each type of cell can develop into a different type of tumor:
Epithelial tumors start from the cells that cover the outer surface of the ovary. Most ovarian tumors are epithelial cell tumors.
Germ cell tumors start from the cells that produce the eggs (ova).
Stromal tumors start from structural tissue cells that hold the ovary together and produce the female hormones estrogen and progesterone.
Epithelial ovarian tumors develop from the cells that cover the outer surface of the ovary. Most epithelial ovarian tumors are benign. There are several types of benign epithelial tumors, including serous adenomas, mucinous adenomas, and Brenner tumors. Cancerous epithelial tumors are carcinomas - meaning they begin in the tissue that lines the ovaries.
There are some ovarian epithelial tumors whose appearance under the microscope does not clearly identify them as cancerous and they are called borderline tumors or tumors of low malignant potential (LMP tumors).
Epithelial cancer of the ovary is thought to derive from malignant transformation of the epithelium of the ovarian surface, peritoneum, or fallopian tube. The exact molecular transformation events causing EOC are not known. Studies have shown that epigenetic phenomenon may also play a role. Mutations of the oncogenes HER2, C-myc, K-ras, Akt, and the tumor suppressor gene p53 have been observed.
The clinical presentation of EOC can either be acute or subacute. Acute cases present with conditions such as pleural effusion, small bowel obstruction and venous thromboembolism.
Subacute cases may present with non specific symptoms such as abdominal fullness, bloating, an adnexal mass, vague pelvic or abdominal pain and gastrointestinal symptoms.
During the last decade it has become apparent that EOC encompasses 5 distinct diseases, with different presentations (age of development, distribution of disease), response to chemotherapy, prognosis, molecular features, and site of origin. While these carcinomas share a common site of tumor growth in the ovary, they represent diverse diseases entities. This has driven the move towards more histotype specific management strategies.
Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-market
View Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market
Some of Epithelial Ovarian Cancer Companies:
- Immunogen
- Celsion Corporation
- OncoQuest
- Roche
- Precigen
- Ellipses Pharma
- And Many Others
Epithelial Ovarian Cancer Drugs Covered:
- Mirvetuximab
- GEN-1
- Oregovomab
- Tecentriq
- PRGN-3005 UltraCAR-T
- EP0057
- And Many Others
Request for Free Sample Report: https://www.delveinsight.com/sample-request/epithelial-ovarian-cancer-market
View Report: https://www.delveinsight.com/report-store/epithelial-ovarian-cancer-market
Table of Contents:
- Key Insights
- Executive Summary of Epithelial Ovarian Cancer
- Competitive Intelligence Analysis for Epithelial Ovarian Cancer
- Epithelial Ovarian Cancer: Market Overview at a Glance
- Epithelial Ovarian Cancer: Disease Background and Overview
- Patient Journey
- Epithelial Ovarian Cancer Epidemiology and Patient Population
- Treatment Algorithm, Current Treatment, and Medical Practices
- Unmet Needs
- Key Endpoints of Epithelial Ovarian Cancer Treatment
- Marketed Products
- Emerging Therapies
- Epithelial Ovarian Cancer: Seven Major Market Analysis
- Attribute analysis
- 7MM: Market Outlook
- Access and Reimbursement Overview of Epithelial Ovarian Cancer
- KOL Views
- Market Drivers
- Market Barriers
- Appendix
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Related Reports:
- Tourette Syndrome Pipeline
- Tourette Syndrome Epidemiology
- Rett Syndrome Epidemiology
- Tourette Syndrome Global API
- Tourette Syndrome Market
- Rett Syndrome Pipeline
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: [email protected]
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
The global 'Vital Signs Monitoring Devices market' is expected to gain momentum from their increasing demand from several healthcare institutions to control the spread of the corona virus infection.
The U.S. Food and Drug Administration (FDA), for instance, put forward a new guideline in March 2020 that enables the manufacturers of specific FDA-cleare dsign monitoring devices to broaden their utilization.It would aid the healthcare providers in remotely monitoring patients.
This information is given by Fortune Business Insights™ in a new report, titled, “Vital Signs Monitoring Devices Market Size, Share Impact Analysis, By Type (Pulse-oximeters, Temperature Monitors, Pressure Monitors), By End User (Hospitals and Ambulatory Surgical Centers, Clinics, Home Care Settings and Others), and Regional Forecast, 2020-2027.” The report further states that the market size was USD 4.63 billion in 2019 and is projected to reach USD 11.55 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period.Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/sample/vital-signs-monitoring-devices-market-103359Frequently Ask Question :How much is the vital signs monitoring devices market worth?Fortune Business Insights says that the global vital signs monitoring devices market size was USD 4.63 billion in 2019 and is projected to reach USD 11.55 billion by 2027.
At what CAGR is the market projected to grow in the forecast period (2020-2027)?Growing at a CAGR of 11.0%, the market will exhibit steady growth in the forecast period (2020-2027).This Report Answers the Following Questions:Which is the dominant region in the market?What are the challenges and opportunities in the market?How will the market be affected by COVID-19?Which segment is set to lead the market in the near future?Regional Analysis-Rising Entry of Numerous Manufacturers to Augment Growth in Asia PacificGeographically, North Americagenerated revenue of USD 2.77 billion in 2019 and is anticipated to dominate the market throughout the forthcoming years.
This growth is attributable to the higher incidence of chronic disorders associated with sedentary lifestyle in this region.
This factor may hamper the market growth.Competitive Landscape-Key Players Focus on Launching Advanced Vital Signs Monitoring DevicesThe companies present in the market are persistently investing hefty amounts of money in research and development activities to create technologically advanced products.
DelveInsight's "Cervical Dystonia Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Cervical Dystonia, historical and forecasted epidemiology as well as the Cervical Dystonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.Some key facts of the Cervical Dystonia Market:According to DelveInsight analysis, the prevalence of cervical dystonia, was found to be 0.009% (8.9 per 100,000 persons).In 2017, the prevalence of 0.006% (5.7 per 100,000) in European countries.Cervical dystonia was commonest in patients aged 35–54 years with a prevalence of 44.8 per 1,000,000.Approximately 3 in every 10,000 people (about 90,000) people in the United States are known to suffer from Spasmodic Torticollis.Request for Sample Report @ https://www.delveinsight.com/sample-request/cervical-dystonia-marketView Report: https://www.delveinsight.com/report-store/cervical-dystonia-marketKey facts of the Cervical Dystonia Market report:Cervical Dystonia market report covers a descriptive overview and comprehensive insight of the Cervical Dystonia epidemiology and Cervical Dystonia market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.
)Cervical Dystonia market report provides insights on the current and emerging therapies.
Cervical Dystonia market report offers a global historical and forecasted market covering drug outreach in 7MM.Cervical Dystonia market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Cervical Dystonia market.“According to Delveinsight, A female predominance was noted for most of the primary dystonias with a male to female ratio (M: F) ranging from 1:1.48 to 1:3..”Request for Sample Report @ https://www.delveinsight.com/sample-request/cervical-dystonia-marketView Report: https://www.delveinsight.com/report-store/cervical-dystonia-marketCervical Dystonia (CD) is a chronic neurological disorder characterized by involuntary contractions of the cervical musculature that lead to abnormal movements and postures of the head.
In some cases, these abnormal contractions may be sustained or continuous; in others, they may be present as spasms that can resemble tremor.The pattern of neck muscle involvement in patients with CD is variable, leading to clinically heterogeneous directional presentations, such as torticollis, laterocollis, retrocollis, or anterocollis.
Individuals may also have additional signs and symptoms, such as shoulder elevation, neck/shoulder pain, head oscillation due to dystonic tremor produced by uneven contractions of the cervical muscles, arm tremor, and use sensory tricks.According to National Organizations of Rare Disorders (NORD), cervical dystonia affects women approximately twice as often as men.
It is the most common form of focal dystonia in an office setting.
